A Unified Theory of the Causes of Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma, with a Consequent Treatment Proposal for Long-Term Control and Possible Cure

Wheatley, Carmen
March 2002
Journal of Orthomolecular Medicine;2002 1st Quarter, Vol. 17 Issue 1, p7
Academic Journal
Investigates the causes of multiple myeloma and monoclonal gammopathy of unknown significance (MGUS). Background on epidemiological, biochemical and genetic causes; Hypothesis on the fundamental cause of MGUS and multiple myeloma; Proposals for long-term treatment and control.


Related Articles

  • Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana. Landgren, Ola; Katzmann, Jerry A.; Hsing, Ann W.; Pfeiffer, Ruth M.; Kyle, Robert A.; Yeboah, Edward D.; Biritwum, Richard B.; Tetfey, Yao; Adjei, Andrew A.; Larson, Dirk R.; Dispenzieri, Angela; Melton III, L. Joseph; Goldin, Lynn R.; Mcmaster, Mary L.; Caporaso, Neil E.; Rajkumar, S. Vincent // Mayo Clinic Proceedings;Dec2007, Vol. 82 Issue 12, p1468 

    OBJECTIVES: To determine the prevalence of monoclonal gammopathy of undetermined significance (MGUS), a precursor of multiple myeloma (MM), in Ghanaian men vs white men and to test for evidence to support an underlying race-related predisposition of the 2-fold higher prevalence of MGUS in...

  • Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre. Haynes, Richard J.; Read, Simon; Collins, Graham P.; Darby, Sarah C.; Winearls, Christopher G. // Nephrology Dialysis Transplantation;Feb2010, Vol. 25 Issue 2, p419 

    Background. Myeloma is the second most common haematological malignancy and is a cause of severe acute kidney injury (serum creatinine ≥500 μmol/L) that has long been associated with a poor prognosis, although previous series have been small.

  • Pathogenesis and progression of monoclonal gammopathy of undetermined significance. Bladé, J.; Rosiñol, L.; Cibeira, M. T.; de Larrea, C. F. // Leukemia (08876924);Sep2008, Vol. 22 Issue 9, p1651 

    In Caucasians, monoclonal gammopathy of undetermined significance (MGUS) is an age-related condition with prevalence as high as 3% in persons older than 50 years. Compared with whites, blacks have around two- and threefold higher prevalence rates of MGUS and multiple myeloma (MM), respectively....

  • Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Fonti, R.; Del Vecchio, S.; Zannetti, A.; De Renzo, A.; Di Gennaro, F.; Catalano, L.; Califano, C.; Pace, L.; Rotoli, B.; Salvatore, M. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 2, p214 

    Abstract. In a previous study, we showed the ability of technetium-99m methoxyisobutylisonitrile ([sup 99m]Tc-MIBI) scan to identify active disease in patients with multiple myeloma (Eur J Nucl Med 1998; 25: 714-720). In particular, a semiquantitative score of the extension and intensity of bone...

  • Online CME Quiz Questions. Multiple Myeloma Precursor Disease.  // JAMA: Journal of the American Medical Association;12/1/2010, Vol. 304 Issue 21, p2421 

    A online continuing medical education (CME) quiz about multiple myeloma precursor disease is presented.

  • Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications. Corso, A.; Zappasodi, P.; Pascutto, C.; Bosoni, T.; Mangiacavalli, S.; Lorenzi, A.; Rusconi, C.; Lazzarino, M. // Annals of Hematology;Aug2003, Vol. 82 Issue 8, p487 

    Renal failure is one of the worst complications occurring in multiple myeloma (MM) patients. It does not affect survival if reverted by a prompt chemotherapy before the damage becomes irreversible; therefore, the early diagnosis of renal dysfunction is crucial. High and low molecular weight...

  • Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy. Fonseca, R; Oken, M M; Harrington, D; Bailey, R J; Van Wier, S A; Henderson, K J; Kay, N E; Van Ness, B; Greipp, P R; Dewald, G W // Leukemia (08876924);Jun2001, Vol. 15 Issue 6, p981 

    Deletions of the long arm of chromosome 13 (13q-) are observed in patients with multiple myeloma (MM), are rarely observed in the monoclonal gammopathy of undetermined significance (MGUS) and have been associated with a worsened prognosis in MM. However, no minimally deleted region in the 13q...

  • 4. From MGUS to symptomatic MM.  // Hematology Journal;2003 Supplement, Vol. 4 Issue 1, pS31 

    The Hematology Journal (2003) 4, S31-S34. doi:10.1038/sj.thj.6200271

  • Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Woitge, H W; Pecherstorfer, M; Horn, E; Keck, A-V; Diel, I J; Bayer, P; Ludwig, H; Ziegler, R; Seibel, M J // British Journal of Cancer;2/1/2001, Vol. 84 Issue 3, p344 

    To test the potential of immunoreactive BSP, a non-collagenous bone matrix component, as a clinical guide in patients with plasma cell dyscrasias, serum BSP concentrations were measured in 62 patients with newly diagnosed multiple myeloma (MM) followed over a period of 4 years, in 46 patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics